阅读说明：本技术 用遗传修饰的β细胞治疗糖尿病 (Treatment of diabetes with genetically modified beta cells ) 是由 G.F.斯维斯 D.基夫利奇 于 2018-09-28 设计创作，主要内容包括：本文描述的是用于有此需要的受试者的表达趋除水平的CXCL12的人转基因β细胞。本文还描述的是包含转基因的β细胞,所述转基因包含编码CXCL12的核酸序列。(Described herein are human transgenic beta cells expressing levels of CXCL12 that are prone to decline for use in a subject in need thereof. Also described herein are beta cells comprising a transgene comprising a nucleic acid sequence encoding CXCL 12.)